Maxim initiated coverage of Co-Diagnostics (CODX) with a Buy rating and $1.50 price target
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CODX:
- Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles
- Co-Diagnostics Expands Global Reach and Innovates with AI
- CODX Upcoming Earnings Report: What to Expect?
- Co-Diagnostics selects Maxim Group as financial advisor for CoSara Diagnostics
- Largest borrow rate increases among liquid names